Epizyme - Stock Price History | EPZM

Historical daily share price chart and data for Epizyme since 2021 adjusted for splits. The latest closing stock price for Epizyme as of September 27, 2021 is 5.43.
  • The all-time high Epizyme stock closing price was 43.60 on July 16, 2013.
  • The Epizyme 52-week high stock price is 14.30, which is 163.4% above the current share price.
  • The Epizyme 52-week low stock price is 4.72, which is 13.1% below the current share price.
  • The average Epizyme stock price for the last 52 weeks is 9.35.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Epizyme Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 16.1185 24.9000 26.7200 10.3400 10.8600 -55.85%
2019 12.8964 6.6700 24.6000 5.9800 24.6000 299.35%
2018 12.8550 12.8000 19.7500 5.2200 6.1600 -50.92%
2017 14.5622 12.3000 20.1000 9.7500 12.5500 3.72%
2016 10.2074 15.2800 15.2800 7.1200 12.1000 -24.47%
2015 18.6999 19.8200 25.9800 11.7700 16.0200 -15.10%
2014 27.0503 20.2600 40.4100 16.6800 18.8700 -9.28%
2013 30.6199 22.9900 43.6000 18.9800 20.8000 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.555B $0.016B
Epizyme, Inc. is a biopharmaceutical company. It engages in the discovery, development, planning, and commercialization of therapeutics for cancers. Epizyme, Inc. is headquartered in Cambridge, Massachusetts.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $132.971B 8.85
Bio-Rad Laboratories (BIO.B) United States $22.624B 48.22
QIAGEN (QGEN) Netherlands $12.001B 20.32
Biohaven Pharmaceutical Holding (BHVN) United States $8.691B 0.00
Emergent Biosolutions (EBS) United States $2.870B 6.92
Arcus Biosciences (RCUS) United States $2.690B 0.00
Myovant Sciences (MYOV) United Kingdom $2.182B 0.00
ADC Therapeutics SA (ADCT) Switzerland $2.045B 0.00
Zymeworks (ZYME) Canada $1.373B 0.00
Ambrx Biopharma (AMAM) United States $0.501B 0.00
SQZ Biotechnologies (SQZ) United States $0.442B 0.00
Enzo Biochem (ENZ) United States $0.174B 51.29